Repeated Neural Tube Defects and Valproate Monotherapy Suggest a Pharmacogenetic Abnormality
- 1 June 2001
- Vol. 42 (6) , 750-753
- https://doi.org/10.1046/j.1528-1157.2001.44300.x
Abstract
Valproate (VPA) is an effective, widely used antiepileptic drug. Unfortunately its use in pregnant women is associated with neural tube defects in the offspring. Although the etiology of neural tube defects is multifactorial, there is evidence that underlying genetic susceptibility plays a part. We describe two women taking moderate doses of VPA who repeatedly bore children with neural tube defects, despite folate supplementation. This suggests a pharmacogenetic susceptibility to the teratogenic effects of VPA.Keywords
This publication has 12 references indexed in Scilit:
- Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defectsAmerican Journal of Medical Genetics, 1999
- Congenital malformations due to antiepileptic drugsEpilepsy Research, 1999
- VPA-induced neural tube defects in mice. I. altered metabolism of sulfur amino acids and glutathioneTeratogenesis, Carcinogenesis, and Mutagenesis, 1998
- VPA‐induced neural tube defects in mice. I. altered metabolism of sulfur amino acids and glutathioneTeratogenesis, Carcinogenesis, and Mutagenesis, 1998
- Strain‐dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse modelAmerican Journal of Medical Genetics, 1997
- Strain-dependent alterations in the expression of folate pathway genes following teratogenic exposure to valproic acid in a mouse modelAmerican Journal of Medical Genetics, 1997
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Improved pregnancy outcome in epileptic women in the last decade: Relationship to maternal anticonvulsant therapyBrain & Development, 1992
- Neural-Tube Defects and Derangement of Homocysteine MetabolismNew England Journal of Medicine, 1991
- MATERNAL VALPROIC ACID AND CONGENITAL NEURAL TUBE DEFECTSThe Lancet, 1982